Angiotensin II type 1 receptor-associated protein plays a role in regulating the local renin-angiotensin system in HSC-T6 cells

Molecular Medicine Reports

Volumn 12, Issue 3, 2015, Pages 3763-3768

  Huang, Haiyang ^a   Zhou, Jie ^a   Cui, Zhonglin ^a   Wang, Biao ^a   Hu, Yunwei ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Angiotensin II type 1 receptor associated protein; Hepatic stellate cells; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 12; ANGIOTENSIN CONVERTING ENZYME 18; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN CONVERTING ENZYME 24; ANGIOTENSIN CONVERTING ENZYME 36; ANGIOTENSIN CONVERTING ENZYME 6; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR ASSOCIATED PROTEIN; ANGIOTENSIN[1-7]; DIPEPTIDYL CARBOXYPEPTIDASE; UNCLASSIFIED DRUG; AGTRAP PROTEIN, RAT; ANGIOTENSIN I; ANGIOTENSIN I (1-7); ANGIOTENSIN RECEPTOR; MESSENGER RNA; PEPTIDE FRAGMENT;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; LIVER FIBROSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; WESTERN BLOTTING; ANIMAL; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RAT;

RATTUS;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; PEPTIDE FRAGMENTS; RATS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

EID: 84935481120     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3849     Document Type: Article

References (29)

1. Yu L, Nobel NA and Border WA: Therapeutic strategies to halt renal fibrosis. Curr Opin Pharmacol 2:177-181, 2002.
2. Kim S and Iwao H: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52:11-34, 2000.
3. Unger T: The role of the renin angiotensin system in the development of cardiovascular disease. Am J Cardiol 89:3A-9A, 2002.
4. Warner FJ, Lubel JS, McCaughan GW and Angus PW: Liver fibrosis: a balance of ACEs? Clin Sci (Lond) 113:109-118, 2007.
5. Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, Rumble JR, Kelly DJ, Tikellis C, Cox A, Smallwood RA and Angus PW: Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol 35:376-385, 2001.
6. Munshi MK, Uddin MN and Glaser SS: The role of the renin-angiotensin system in liver fibrosis. Exp Biol Med (Maywood) 236:557-566, 2011.
7. Simões e Silva AC, Pinheiro SV, Pereira RM, Ferreira AJ and Santos RA: The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator. Mini Rev Med Chem 6:603-609, 2006.
8. Carey RM and Siragy HM: Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 24:261-271, 2003.
9. Iwai M and Horiuchi M: Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res 32:533-536, 2009.
10. Pereira RM, dos Santos RA, da Costa Dias FL, Teixeira MM and Simões e Silva AC: Renin-angiotensin system in the pathogenesis of liver fibrosis. World J Gastroenterol 15:2579-2586, 2009.
11. Guo DF, Sun YL, Hamet P and Inagami T: The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res 11:165-180, 2001.
12. Wang W, Huang Y, Zhou Z, Tang R, Zhao W, Zeng L, Xu M, Cheng C, Gu S, Ying K, Xie Y and Mao Y: Identification and characterization of AGTRAP, a human homolog of murine angiotensin II receptor-associated protein (Agtrap). Int J Biochem Cell Biol 34:93-102, 2002.
13. Lopez-Ilasaca M, Liu X, Tamura K and Dzau VJ: The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell 14:5038-5050, 2003.
14. Tamura K, Wakui H, Maeda A, Dejima T, Ohsawa M, Azushima K, Kanaoka T, Haku S, Uneda K, Masuda S, Azuma K, Shigenaga A, Koide Y, Tsurumi-Ikeya Y, Matsuda M, Toya Y, Tokita Y, Yamashita A and Umemura S: The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap. Curr Pharm Des 19:3043-3048, 2013.
15. Wakui H, Tamura K, Masuda S, et al: Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension. Hypertension 61:1203-1210, 2013.
16. Wakui H, Tamura K, Matsuda M, Bai Y, Dejima T, Shigenaga A, Masuda S, Azuma K, Maeda A, Hirose T, Ishigami T, Toya Y, Yabana M, Minamisawa S and Umemura S: Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice. Am J Physiol Renal Physiol 299:F991-F1003, 2010.
17. Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL and Blaner WS: An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 41:882-893, 2000.
18. Bataller R, Sancho-Bru P, Ginès P, Lora JM, Al-Garawi A, Solé M, Colmenero J, Nicolás JM, Jiménez W, Weich N, Gutirrez-Ramos JC, Arroyo V and Rodés J: Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 125:117-125, 2003.
19. Daviet L, Lehtonen JY, Tamura K, Griese DP, Horiuchi M and Dzau VJ: Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J Biol Chem 274:17058-17062, 1999
20. Cui T, Nakagami H, Iwai M, Takeda Y, Shiuchi T, Tamura K, Daviet L and Horiuchi M. ATRAP, novel AT1 receptor associated protein, enhances internalization of AT1 receptor and inhibits vascular smooth muscle cell growth. Biochem Biophys Res Commun 279:938-941, 2000.
21. Wakui H, Tamura K, Tanaka Y, Matsuda M, Bai Y, Dejima T, Masuda S, Shigenaga A, Maeda A, Mogi M, Ichihara N, Kobayashi Y, Hirawa N, Ishigami T, Toya Y, Yabana M, Horiuchi M, Minamisawa S and Umemura S: Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice. Hypertension 55:1157-1164, 2010.
22. Wakui H, Dejima T, Tamura K, Uneda K, Azuma K, Maeda A, Ohsawa M, Kanaoka T, Azushima K, Kobayashi R, Matsuda M, Yamashita A and Umemura S: Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension. Cardiovasc Res 100:511-519, 2013.
23. Oppermann M, Gess B, Schweda F and Castrop H: Atrap deficiency increases arterial blood pressure and plasma volume. J Am Soc Nephrol 21:468-477, 2010.
24. Li Z, Wang ZG, Chen X and Chen XD. Inhibitory effect of angiotensin II type 1 receptor-associated protein on vascular smooth muscle cell growth and neointimal formation. Chin Med Sci J 22:22-26, 2007.
25. Tanaka Y, Tamura K, Koide Y, et al: The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy. FEBS Lett 579:1579-1586, 2005.
26. Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM and Angus PW: Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. Clin Sci (Lond) 117:375-386, 2009.
27. Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI and Gallagher PE: Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111:2605-2610, 2005.
28. Igase M, Strawn WB, Gallagher PE, Geary RL and Ferrario CM: Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 289:H1013-H1019, 2005.
29. Tan Z, Wu J and Ma H: Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1-7) in heart and kidney of spontaneously hypertensive rats. J Renin Angiotensin Aldosterone Syst 12:413-419, 2011.